These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7067729)

  • 21. Caffeine potentiation of apomorphine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Aug; 13(2):307-9. PubMed ID: 6251484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of pentazocine as a discriminative stimulus in the squirrel monkey.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1982 Nov; 223(2):396-401. PubMed ID: 7131294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric relaxation and vomiting by apomorphine, morphine and fentanyl in the conscious dog.
    Lefebvre RA; Willems JL; Bogaert MG
    Eur J Pharmacol; 1981 Jan; 69(2):139-45. PubMed ID: 7202514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of loperamide, haloperidol and methadone in rats trained to discriminate morphine from saline.
    Gianutsos G; Lal H
    Psychopharmacologia; 1975; 41(3):267-70. PubMed ID: 1153614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ergometrine and apomorphine as selective antagonists of dopamine in the canine renal vasculature.
    Bell C; Conway EL; Lang WJ
    Br J Pharmacol; 1974 Dec; 52(4):591-5. PubMed ID: 4455334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D2 receptors and spinal cord excitation in mice.
    Hasegawa Y; Kurachi M; Otomo S
    Eur J Pharmacol; 1990 Aug; 184(2-3):207-12. PubMed ID: 2150374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys.
    Woolverton WL; Kamien JB; Goldberg LI
    J Pharmacol Exp Ther; 1987 Apr; 241(1):213-7. PubMed ID: 3553538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect on morphine hyperthermia of dopaminergic agents].
    Iakimova K; Koleva E; Bantutova I; Ovcharova R
    Eksp Med Morfol; 1985; 24(4):21-7. PubMed ID: 3833520
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of dopamine receptors in gastrointestinal motility.
    Dhasmana KM; Banerjee AK; Zhu YN; Erdmann W; Parmar SS; Salzman SK
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):485-8. PubMed ID: 2571179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of morphine with apomorphine: behavioural and biochemical studies.
    Möller HG; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):452-7. PubMed ID: 3821935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride.
    Cohen C; Sanger DJ; Perrault G
    J Pharmacol Exp Ther; 1997 Nov; 283(2):566-73. PubMed ID: 9353371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
    Kuhn DM; Greenberg I; Appel JB
    J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice.
    Doğrul A; Yeşilyurt O
    Eur J Pharmacol; 1999 Jan; 364(2-3):175-82. PubMed ID: 9932721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apomorphine as a discriminative stimulus, and its antagonism by haloperidol.
    Colpaert FC; Niemegeers CJ; Kuyps JJ; Janssen PA
    Eur J Pharmacol; 1975; 32(02):383-6. PubMed ID: 1149818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.